Physician profile
Robert E Littleton
NPI 1982694089
$60,583.92
in general payments reported to CMS, 2019-2025
38 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54K · 2020: $5,414 · 2021: $1,465 · 2022: $34.30.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $56,148.61 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $1,972.14 | 2019-2020 | |
| Intuitive Surgical, INC. | $464.04 | 2021 | |
| Amgen INC. | $318.69 | 2019-2021 | |
| Daiichi Sankyo INC. | $250.76 | 2019-2021 | |
| Therapeuticsmd, INC. | $167.19 | 2019-2021 | |
| Avion Pharmaceuticals | $159.40 | 2019-2021 | |
| Hologic Sales and Service, LLC | $145.58 | 2020 | |
| Pfizer INC. | $118.25 | 2019-2021 | |
| Alydia Health | $91.49 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $90.58 | 2019-2020 | |
| Evofem Biosciences, INC. | $72.61 | 2021 | |
| Lupin INC. | $54.01 | 2020-2021 | |
| Baxter Healthcare | $53.77 | 2021-2022 | |
| Ethicon US, LLC | $52.97 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $43.90 | 2019 | |
| Aspira Women'S Health INC | $39.01 | 2021 | |
| Medicem INC. | $31.52 | 2020 | |
| Astellas Pharma US INC | $28.91 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $28.62 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $27.55 | 2021 | |
| Coopersurgical, INC. | $26.56 | 2019 | |
| Exeltis, USA INC. | $25.41 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $24.46 | 2021 | |
| Sage Therapeutics, LLC | $21.67 | 2021 | |
| Agile Therapeutics, INC. | $19.30 | 2021 | |
| Allergan, INC. | $16.51 | 2020 | |
| Merck Sharp & Dohme LLC | $16.34 | 2019 | |
| Vertical Pharmaceuticals, LLC | $15.99 | 2019 | |
| Myovant Sciences INC. | $15.34 | 2021 | |
| Bausch Health US, LLC | $15.30 | 2020 | |
| Glaxosmithkline, LLC. | $14.83 | 2020 | |
| Meditrina | $12.61 | 2019 |
5 companies reported research payments only; those appear in the research section below.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Littleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.